This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
26 Apr 2011

Bayer & OncoMed Sign Clinical Mfg Deal

Bayer will manufacture the bulk drug substance at its Berkeley, CA clinical manufacturing center to support Phase I testing, which expected to begin in 2012.

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics targeting cancer stem cells, announced last week it has expanded its collaboration with Bayer HealthCare.

 

Under the agreement, Bayer will manufacture clinical supplies of a second Wnt inhibitor. Bayer will manufacture the bulk drug substance at its Berkeley, CA clinical manufacturing center to support Phase I testing, which expected to begin in 2012.

 

"We are pleased to announce this expansion of our partnership with Bayer,” said Paul Hastings, president and chief executive officer of OncoMed Pharmaceuticals. “We continue to make significant progress in our Wnt pathway programs, and this manufacturing a

Related News